Related Experiment Video
Updated: Aug 11, 2026
08:02
Generation of Local CA1 γ Oscillations by Tetanic Stimulation
Published on: August 14, 2015
[Tiagabine: recent findings and recommendations for dosage]
1Universidad de Cantabria, Hospital Universitario Marqués de Valdecilla, Santander, España.
Revista De Neurologia
|July 23, 1998
Summary
Tiagabine is an effective antiepileptic drug that inhibits GAT-1, increasing GABA in synapses. It shows significant efficacy in complex partial seizures, with a 53% complete control rate in new patients.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Tiagabine functions by inhibiting the GAT-1 transporter protein.
- This inhibition prolongs the synaptic presence of gamma-aminobutyric acid (GABA).
Purpose of the Study:
- To evaluate the efficacy and dosing of tiagabine.
- To assess tiagabine's effectiveness in patients with complex partial seizures.
Main Methods:
- Pharmacokinetic analysis of tiagabine.
- Gradual dose titration starting at 15 mg/day.
Main Results:
- Tiagabine achieved complete seizure control in 53% of new patients treated monotherapeutically.
- Infrequent side effects were observed, particularly with gradual dose escalation.
- The effective dose ranged from 15 to 30 mg/day.
Conclusions:
- Tiagabine is a well-tolerated and effective monotherapy for complex partial seizures.
- Optimal dosing involves gradual titration to a maintenance level of 15-30 mg/day.
Related Concept Videos
01:15Drug Dosage Regimen: Overview
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
01:01Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...